TULLIS HEALTH INVESTORS

Thesis

Tullis Health Investors is a growth equity firm established in 1986, specializing in the healthcare sector with a geographic focus on North America. They target high-growth, commercial-stage healthcare companies possessing novel and differentiated technologies with substantial addressable markets. By concentrating on companies that have already achieved commercialization, Tullis aims to mitigate regulatory and technology development risks. While they invest across all stages, they have demonstrated particular effectiveness in later-stage and growth equity investments. Their industry preferences span Medical Devices, Healthcare Services, Healthcare Infrastructure & Distribution, Healthcare Information Technology, Biotechnology, and Pharmaceuticals. The firm manages a family of private funds, with reported AUM of approximately $143 million across 9 funds. Deal sizes typically range from $10 million to $50 million, with some sources indicating a minimum check size of $500K and a maximum of $10M for specific funds.